[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Generate Biomedicines Inc (GENB)

Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,162,599
  • Shares Outstanding, K 128,192
  • Annual Sales, $ 31,890 K
  • Annual Income, $ -203,150 K
  • EBIT $ -112 M
  • EBITDA $ -102 M
  • 60-Month Beta N/A
  • Price/Sales 67.97
  • Price/Cash Flow N/A
  • Price/Book 4.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.48
  • Number of Estimates 3
  • High Estimate $-0.46
  • Low Estimate $-0.51
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.88 +42.00%
on 06/02/26
18.18 -7.21%
on 06/30/26
+3.75 (+28.58%)
since 05/29/26
3-Month
11.10 +51.98%
on 04/10/26
18.18 -7.21%
on 06/30/26
+5.36 (+46.57%)
since 03/30/26

Most Recent Stories

More News
AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts

Newly Constructed Phase 2 now 100% Leased

GENB : 16.87 (-0.24%)
Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

SOMERVILLE, Mass. , May 28, 2026 /PRNewswire/ -- Generate Biomedicines, Inc. (NASDAQ: GENB) today announced that it intends to participate in the Goldman Sachs Global Healthcare Conference on Monday,...

GENB : 16.87 (-0.24%)
This AI Biotech Stock Landed a $10.4 Million Nvidia Investment

Nvidia’s backing highlights growing confidence in AI-powered biotech stocks.

NVDA : 200.09 (+2.63%)
GENB : 16.87 (-0.24%)
NVS : 156.72 (-0.55%)
AMGN : 362.12 (+0.44%)
A Deep Dive Into NVIDIA’s Latest Portfolio Moves

NVIDIA's latest 13F filing does not tell the story it seems to at first glance. The apparent divergence in its CoreWeave and Nebius holdings is a prime example.

NVDA : 200.09 (+2.63%)
CRWV : 99.54 (+4.22%)
GENB : 16.87 (-0.24%)
INTC : 139.63 (+6.01%)
SNPS : 446.07 (-0.27%)
COHR : 394.47 (+0.83%)
NBIS : 276.17 (+5.75%)
RXRX : 3.67 (-0.54%)
NOK : 13.28 (+1.92%)
LITE : 858.06 (+0.78%)
MRVL : 297.89 (+7.25%)
Generate Biomedicines: Q1 Earnings Snapshot

Generate Biomedicines: Q1 Earnings Snapshot

GENB : 16.87 (-0.24%)
Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update

SOMERVILLE, Mass. , May 7, 2026 /PRNewswire/ -- Generate Biomedicines, Inc. (NASDAQ: GENB) ("Generate") today reported financial results for the first quarter ended March 31, 2026, and highlighted...

GENB : 16.87 (-0.24%)
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering

SOMERVILLE, Mass. , Feb. 26, 2026 /PRNewswire/ -- Generate Biomedicines, Inc. (Nasdaq: GENB) ("Generate"), a clinical-stage generative biology company pioneering the AI revolution in biotechnology...

GENB : 16.87 (-0.24%)

Key Turning Points

3rd Resistance Point 19.87
2nd Resistance Point 19.02
1st Resistance Point 17.95
Last Price 16.87
1st Support Level 16.03
2nd Support Level 15.18
3rd Support Level 14.11

See More

52-Week High 18.18
Last Price 16.87
Fibonacci 61.8% 15.44
Fibonacci 50% 14.59
Fibonacci 38.2% 13.74
52-Week Low 11.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.